Dr. Edwards has offered to meet with researchers throughout the day on Feb 17 to discuss open science. If you are interested, please reach out to Paul Pavlidis (firstname.lastname@example.org). Trainees are welcome to meet with Dr. Edwards after his talk from 2:30-3:30pm.
Please note this event is scheduled to be in person. If you cannot attend, below is the Zoom information:
Society has decided that the development of new medicines is the role of the private sector, and supports this decision with a range of policies.
And while this drug development system has produced remarkable discoveries, the “maximize profit” structure of the ecosystem has consequences. Some diseases are not explored because of a lack of market incentive, and access to new medicines is not equitable.
Within this backdrop, Dr. Edwards will argue that universities, through their tech transfer policies, are complicit in this inequitable system, and we should develop new policies and models in which equitable access is the priority.
Open science is a tactic to this end, and Dr. Edwards will describe several drug discovery projects that that have been initiated under the open science framework, as well as the legal and business frameworks that we are developing to ensure we get the drugs to market.